{"id":"gi-medication","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without access to the specific drug name or identifier, the exact mechanism cannot be determined. GI medications typically work through various pathways such as acid suppression, motility enhancement, anti-inflammatory effects, or microbiome modulation depending on the therapeutic target.","oneSentence":"This is a gastrointestinal medication developed by East Carolina University, but specific mechanism details are not publicly available.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:31:06.494Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gastrointestinal disorder (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT06557733","phase":"PHASE2","title":"An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-08-22","conditions":"Colorectal Carcinoma, Familial Adenomatous Polyposis","enrollment":38},{"nctId":"NCT05930197","phase":"PHASE1","title":"Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-08-31","conditions":"Healthy Adults","enrollment":34},{"nctId":"NCT07483658","phase":"NA","title":"Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.","status":"NOT_YET_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2026-02","conditions":"Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy), Prostate Cancer","enrollment":434},{"nctId":"NCT05639556","phase":"","title":"Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2023-04-20","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT03876288","phase":"","title":"Gastroparesis Outcome Longitudinal Database Enrolled Numerically","status":"RECRUITING","sponsor":"University of Louisville","startDate":"2013-01-01","conditions":"Gastroparesis","enrollment":3000},{"nctId":"NCT03819296","phase":"PHASE1","title":"Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-21","conditions":"Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8","enrollment":800},{"nctId":"NCT07229313","phase":"PHASE1","title":"A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Kivu Bioscience Inc.","startDate":"2025-11-13","conditions":"Advance Solid Tumors","enrollment":76},{"nctId":"NCT06162715","phase":"PHASE2, PHASE3","title":"GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2024-10-30","conditions":"Severe Obesity, Obesity, BMI Greater Than 30","enrollment":30},{"nctId":"NCT04945330","phase":"","title":"NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes","status":"RECRUITING","sponsor":"Bayer","startDate":"2021-11-05","conditions":"Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion","enrollment":100},{"nctId":"NCT04142437","phase":"","title":"Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body","status":"RECRUITING","sponsor":"Bayer","startDate":"2020-04-03","conditions":"Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion","enrollment":150},{"nctId":"NCT05677113","phase":"PHASE2","title":"A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-08-01","conditions":"Colorectal Cancer, Liver Metastases","enrollment":115},{"nctId":"NCT07423676","phase":"","title":"Comparison Between Two Drugs in Sedation of Upper GI Endoscopy","status":"NOT_YET_RECRUITING","sponsor":"Zagazig University","startDate":"2026-03-01","conditions":"Sedation During GI Endoscopy","enrollment":52},{"nctId":"NCT07402434","phase":"","title":"A Prospective Study of Advanced Diagnostics in People With an Unclear Diagnosis of Cystic Fibrosis","status":"NOT_YET_RECRUITING","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2026-02-02","conditions":"Cystic Fibrosis (CF), CFTR-related Disorders","enrollment":80},{"nctId":"NCT05787587","phase":"PHASE1","title":"A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors","status":"RECRUITING","sponsor":"IDEAYA Biosciences","startDate":"2023-04-18","conditions":"Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer","enrollment":216},{"nctId":"NCT06266663","phase":"","title":"Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2024-04-26","conditions":"Inflammatory Bowel Diseases","enrollment":400},{"nctId":"NCT07148583","phase":"NA","title":"BioAmicus Complete for Functional Gastrointestinal Symptoms in Infants Aged 0 to 24 Months","status":"RECRUITING","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2025-09-05","conditions":"Infantile Colic, Gastroesophageal Reflux (GER), Functional Constipation","enrollment":110},{"nctId":"NCT06393868","phase":"PHASE3","title":"Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2024-11-06","conditions":"Venous Thromboembolism, Gastro Intestinal Bleeding, Blood Clot","enrollment":360},{"nctId":"NCT02087826","phase":"NA","title":"Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2014-04","conditions":"Genetics, Metabolism, Type 2 Diabetes","enrollment":1017},{"nctId":"NCT07216560","phase":"PHASE1, PHASE2","title":"First-in-human Study of 7MW4911 in GI Cancer","status":"RECRUITING","sponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","startDate":"2026-01-13","conditions":"GI Cancers","enrollment":200},{"nctId":"NCT05692596","phase":"","title":"The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2022-10-06","conditions":"Pancreatic Ductal Adenocarcinoma, Pancreatic Cyst, Chronic Pancreatitis","enrollment":317},{"nctId":"NCT05093959","phase":"PHASE2","title":"Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-01-04","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":86},{"nctId":"NCT06952920","phase":"PHASE3","title":"Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2025-08-21","conditions":"Standard Quadruple Antiemetic Therapy, Electroacupuncture, Chemotherapy-induced Gastrointestinal Symptom Cluster","enrollment":388},{"nctId":"NCT06331403","phase":"NA","title":"Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2024-07-10","conditions":"Colorectal Cancer, Anal Cancer, Sexual Dysfunction","enrollment":6},{"nctId":"NCT06374251","phase":"NA","title":"Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2023-09-27","conditions":"Malignant Digestive System Neoplasm","enrollment":8},{"nctId":"NCT03385655","phase":"PHASE2","title":"Prostate Cancer Biomarker Enrichment and Treatment Selection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-08-01","conditions":"Prostate Cancer","enrollment":200},{"nctId":"NCT07125651","phase":"","title":"Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-01","conditions":"Gastro Intestinal Bleeding, Ischaemic Heart Diseases, Antiplatelet Drugs","enrollment":112},{"nctId":"NCT04960566","phase":"NA","title":"Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of Gastroesophageal Reflux Disease (GERD)","status":"ENROLLING_BY_INVITATION","sponsor":"Northwestern University","startDate":"2022-04-19","conditions":"Gastroesophageal Reflux","enrollment":250},{"nctId":"NCT05747534","phase":"PHASE2","title":"AT1001 for the Treatment of Long COVID","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-05-31","conditions":"Long COVID, Long COVID-19, Post Acute COVID-19 Syndrome","enrollment":150},{"nctId":"NCT07081035","phase":"PHASE4","title":"Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-10","conditions":"Advanced Heart Failure, Left Ventricular Assist Devices, Anticoagulation Treatment","enrollment":94},{"nctId":"NCT06755372","phase":"","title":"The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Population","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Periodontitis, End-stage Renal Disease","enrollment":100},{"nctId":"NCT05482516","phase":"PHASE3","title":"Evaluating Novel Therapies in ctDNA Positive GI Cancers","status":"RECRUITING","sponsor":"Georgetown University","startDate":"2023-03-29","conditions":"Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma","enrollment":20},{"nctId":"NCT06077487","phase":"PHASE4","title":"Ketamine-assisted Therapy for Advanced GI Cancer","status":"TERMINATED","sponsor":"Brian Anderson, MD","startDate":"2024-05-17","conditions":"Pancreatic Ductal Adenocarcinoma, Pain, Acute, Gastrointestinal Cancers","enrollment":1},{"nctId":"NCT06975917","phase":"","title":"Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ankara University","startDate":"2024-11-01","conditions":"Biliary Tract Cancer, Biliary Tract Cancers (BTC)","enrollment":600},{"nctId":"NCT06431308","phase":"NA","title":"Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events","status":"RECRUITING","sponsor":"Ariel University","startDate":"2025-01-30","conditions":"Obesity; Drug","enrollment":120},{"nctId":"NCT06651255","phase":"NA","title":"Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2025-04","conditions":"Von Willebrand Disease (VWD)","enrollment":66},{"nctId":"NCT06211062","phase":"PHASE2","title":"The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome","status":"RECRUITING","sponsor":"Nova Southeastern University","startDate":"2022-12-20","conditions":"ME/CFS, IBS - Irritable Bowel Syndrome","enrollment":100},{"nctId":"NCT04349371","phase":"PHASE2","title":"Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID","status":"TERMINATED","sponsor":"Columbia University","startDate":"2020-04-21","conditions":"COVID, Coronavirus Infection","enrollment":5},{"nctId":"NCT05956314","phase":"PHASE1","title":"Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC","status":"COMPLETED","sponsor":"Kamari Pharma Ltd","startDate":"2023-03-06","conditions":"Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita","enrollment":18},{"nctId":"NCT03368963","phase":"PHASE1, PHASE2","title":"TAS102 in Combination With NAL-IRI in Advanced GI Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2018-01-30","conditions":"Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma","enrollment":64},{"nctId":"NCT05435638","phase":"PHASE1","title":"Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases","status":"COMPLETED","sponsor":"Kamari Pharma Ltd","startDate":"2022-07-17","conditions":"Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita","enrollment":14},{"nctId":"NCT05113264","phase":"NA","title":"'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2021-08-02","conditions":"Gastrointestinal Cancer","enrollment":60},{"nctId":"NCT04769895","phase":"PHASE3","title":"MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"MaaT Pharma","startDate":"2022-03-25","conditions":"Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD","enrollment":66},{"nctId":"NCT04535401","phase":"PHASE1","title":"Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-08-13","conditions":"Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma","enrollment":10},{"nctId":"NCT04861987","phase":"PHASE1","title":"A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors","status":"COMPLETED","sponsor":"Processa Pharmaceuticals","startDate":"2021-06-18","conditions":"Advanced Cancer, Refractory Cancer, Tumor Gastric","enrollment":23},{"nctId":"NCT02800668","phase":"","title":"Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Ruhr University of Bochum","startDate":"2011-10","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":19},{"nctId":"NCT05183529","phase":"NA","title":"Monitoring Vital Signs With a Wireless Ingestible Device in Subjects Undergoing Polysomnography","status":"COMPLETED","sponsor":"Celero Systems, Inc.","startDate":"2021-12-14","conditions":"Sleep","enrollment":20},{"nctId":"NCT06107777","phase":"NA","title":"The Effectiveness of Pharmacopuncture on Psychological Stress","status":"COMPLETED","sponsor":"Jaseng Medical Foundation","startDate":"2023-11-20","conditions":"Psychological Stress","enrollment":50},{"nctId":"NCT04931420","phase":"PHASE2","title":"Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2022-05-19","conditions":"Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma","enrollment":""},{"nctId":"NCT05563714","phase":"NA","title":"Anticoagulation With Enhanced Gastrointestinal Safety","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2022-10-05","conditions":"Upper Gastrointestinal Bleeding, Peptic Ulcer Hemorrhage, Anticoagulant-induced Bleeding","enrollment":341},{"nctId":"NCT03874897","phase":"PHASE1","title":"Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.","status":"COMPLETED","sponsor":"Peking University","startDate":"2019-03-26","conditions":"Advanced Solid Tumor","enrollment":134},{"nctId":"NCT03329950","phase":"PHASE1","title":"A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies","status":"COMPLETED","sponsor":"Celldex Therapeutics","startDate":"2017-12-01","conditions":"Melanoma, Non-small Cell Lung Cancer, Breast Cancer","enrollment":132},{"nctId":"NCT06269302","phase":"","title":"Comparison of the Effect of Warfarin and Direct Oral Anticoagulants","status":"COMPLETED","sponsor":"Samsun Education and Research Hospital","startDate":"2022-01-01","conditions":"Anticoagulants and Bleeding Disorders, Gastrointestinal Hemorrhage","enrollment":346},{"nctId":"NCT04990804","phase":"PHASE4","title":"Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2021-08-01","conditions":"Opioid Use, Spinal Diseases, Surgery--Complications","enrollment":8},{"nctId":"NCT03198416","phase":"NA","title":"Pharyngeal Anatomy In Obstructive Sleep Apnea With HRM","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-12-11","conditions":"Obstructive Sleep Apnea","enrollment":60},{"nctId":"NCT05718505","phase":"NA","title":"Comparison of the Atmo Motility Gas Capsule System to the Reference Standard","status":"UNKNOWN","sponsor":"Atmo Biosciences Pty Ltd","startDate":"2023-06-05","conditions":"Gastroparesis, Slow Transit Constipation, IBS","enrollment":209},{"nctId":"NCT06173739","phase":"NA","title":"Peri-implant Phenotype, Calprotectin and Mmp-8 Levels in Cases Diagnosed With Peri-implant Disease","status":"COMPLETED","sponsor":"Beliz Önder","startDate":"2020-08-21","conditions":"Peri-implant Mucositis, Peri-Implantitis","enrollment":39},{"nctId":"NCT06167837","phase":"PHASE4","title":"Metoclopramide for Gastric Visualization in Active Upper GI Bleeding","status":"UNKNOWN","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2023-10-01","conditions":"Upper GI Bleeding","enrollment":220},{"nctId":"NCT05769829","phase":"","title":"ImmuneSense™ IBD Study","status":"TERMINATED","sponsor":"Adaptive Biotechnologies","startDate":"2022-10-31","conditions":"Inflammatory Bowel Diseases","enrollment":484},{"nctId":"NCT05022524","phase":"PHASE1","title":"Exploring Novel Uses of Microbiota Therapy for Managing the Side Effects of Psychiatric Pharmaceutical Interventions","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2022-06-01","conditions":"Depression, Anxiety","enrollment":10},{"nctId":"NCT04771481","phase":"PHASE4","title":"Metoclopramide for Acute Upper GI Bleeding","status":"COMPLETED","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2021-04-10","conditions":"Acute Upper Gastrointestinal Bleeding, Effect of Drug","enrollment":68},{"nctId":"NCT06045832","phase":"NA","title":"Oral Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Changhai Hospital","startDate":"2023-03-01","conditions":"H. Pylori Infection","enrollment":42},{"nctId":"NCT05798533","phase":"PHASE1","title":"Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)","status":"UNKNOWN","sponsor":"BGI, China","startDate":"2023-01-10","conditions":"Solid Tumor","enrollment":6},{"nctId":"NCT05085405","phase":"NA","title":"Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-10-11","conditions":"Upper Gastrointestinal Bleeding","enrollment":80},{"nctId":"NCT05922358","phase":"PHASE2","title":"Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors","status":"NOT_YET_RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2023-09-01","conditions":"Gastrointestinal Tumors","enrollment":500},{"nctId":"NCT03827655","phase":"PHASE2","title":"A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2019-03-07","conditions":"Postoperative Gastrointestinal Dysfunction","enrollment":209},{"nctId":"NCT03917420","phase":"PHASE1","title":"Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI Tract","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-03-26","conditions":"HIV/AIDS","enrollment":10},{"nctId":"NCT05798546","phase":"PHASE1","title":"Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)","status":"UNKNOWN","sponsor":"BGI, China","startDate":"2022-09-28","conditions":"Solid Tumor","enrollment":21},{"nctId":"NCT03177681","phase":"NA","title":"The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-03-01","conditions":"Malignant Neoplasms of Independent (Primary) Multiple Sites","enrollment":""},{"nctId":"NCT02798458","phase":"NA","title":"Evaluation of the Gastrointestinal Manifestation of Fabry's Disease","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2016-05","conditions":"Fabry's Disease","enrollment":48},{"nctId":"NCT03824587","phase":"PHASE2, PHASE3","title":"Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy","status":"COMPLETED","sponsor":"Ardelyx","startDate":"2019-02-28","conditions":"Hyperphosphatemia","enrollment":236},{"nctId":"NCT03183115","phase":"NA","title":"RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection","status":"RECRUITING","sponsor":"E-DA Hospital","startDate":"2016-04-18","conditions":"Esophageal Squamous Cell Neoplasm","enrollment":100},{"nctId":"NCT02977286","phase":"PHASE4","title":"Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2017-01-01","conditions":"Constipation","enrollment":12},{"nctId":"NCT05720598","phase":"NA","title":"Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer","status":"UNKNOWN","sponsor":"Medical University of Lublin","startDate":"2022-11-04","conditions":"Gastric Cancer, Lymph Node Metastasis","enrollment":190},{"nctId":"NCT02736968","phase":"PHASE2","title":"Auranofin for Giardia Protozoa","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-11-06","conditions":"Amoebic Dysentery, Giardiasis","enrollment":93},{"nctId":"NCT03039790","phase":"PHASE2","title":"Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-02-21","conditions":"Healthy Volunteers, Norovirus","enrollment":528},{"nctId":"NCT02446834","phase":"NA","title":"Research of Intensive Lifestyle Intervention for PCOS Patients With IGT","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2015-04","conditions":"Polycystic Ovary Syndrome","enrollment":40},{"nctId":"NCT04534101","phase":"","title":"Medical Mindfulness: Virtual Reality Mindfulness Therapy for Anxiety and Pain Management in Patients With Acute and Chronic Pain","status":"SUSPENDED","sponsor":"Stanford University","startDate":"2018-07-10","conditions":"Acute Pain, Chronic Pain","enrollment":500},{"nctId":"NCT04611035","phase":"","title":"Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer)","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2020-01-20","conditions":"Gastrointestinal Cancer","enrollment":100},{"nctId":"NCT04190914","phase":"NA","title":"Different Treatment Modality in Necrotic Primary Molars","status":"COMPLETED","sponsor":"dina darwish","startDate":"2020-02-07","conditions":"Primary Teeth, Dental Pulp Regeneration","enrollment":54},{"nctId":"NCT04983498","phase":"PHASE4","title":"Enhanced Recovery Pathway for Endoscopy","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2021-09-01","conditions":"Enhanced Recovery Pathway, Endoscopy","enrollment":""},{"nctId":"NCT04979273","phase":"NA","title":"The Role of Hypertonic Dextrose Spray as Endoscopic Topical Hemostatic Agent for Acute Non-Variceal Upper GI Bleeding","status":"UNKNOWN","sponsor":"Dr Cipto Mangunkusumo General Hospital","startDate":"2021-03-01","conditions":"Gastro Intestinal Bleeding","enrollment":66},{"nctId":"NCT02669121","phase":"PHASE2","title":"Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2016-06-14","conditions":"Healthy Volunteers","enrollment":4748},{"nctId":"NCT04867512","phase":"NA","title":"Botanical Blend on the Gut Microbiome and Gut-Skin-Axis in Small Intestinal Bacterial Overgrowth (SIBO)","status":"UNKNOWN","sponsor":"Integrative Skin Science and Research","startDate":"2021-04-27","conditions":"Small Intestinal Bacterial Overgrowth (SIBO)","enrollment":35},{"nctId":"NCT04188691","phase":"PHASE1","title":"A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine","status":"COMPLETED","sponsor":"National Vaccine and Serum Institute, China","startDate":"2019-11-28","conditions":"Norwalk Gastroenteritis, Norovirus Infections","enrollment":510},{"nctId":"NCT02928939","phase":"","title":"Therapeutic Conflicts and Multimorbidity","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2016-10","conditions":"Gastrointestinal Hemorrhage, Diabetes Complications, Multimorbidity","enrollment":1101},{"nctId":"NCT03449030","phase":"PHASE1","title":"A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)","status":"TERMINATED","sponsor":"Millennium Pharmaceuticals, Inc.","startDate":"2018-04-23","conditions":"Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies","enrollment":31},{"nctId":"NCT03625674","phase":"NA","title":"Impact of Stigma on Compliance to Medication in Functional Dyspepsia","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2017-09-01","conditions":"Functional Gastrointestinal Disorders, Adherence, Patient","enrollment":220},{"nctId":"NCT02017379","phase":"NA","title":"Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.","status":"TERMINATED","sponsor":"Texas Tech University Health Sciences Center, El Paso","startDate":"2014-06","conditions":"Upper Gastrointestinal Bleeding","enrollment":4},{"nctId":"NCT00373685","phase":"PHASE4","title":"GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-10","conditions":"Osteoarthritis","enrollment":8067},{"nctId":"NCT04622475","phase":"NA","title":"Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHD","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2020-11","conditions":"Steroid-refractory Gastrointestinal Acute Graft Versus Host Disease","enrollment":10},{"nctId":"NCT04597073","phase":"NA","title":"Measurement of Oncostatin M, Leukemia Inhibitory Factor and Interleukin-11 Levels of Patients With Periodontal Disease","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2014-03","conditions":"Chronic Periodontitis, Generalized, Gingivitis","enrollment":72},{"nctId":"NCT03258216","phase":"","title":"TCM Tongue Diagnosis Indices of UGI Disorders","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-01-01","conditions":"Upper Gastrointestinal Disorders","enrollment":134},{"nctId":"NCT02887235","phase":"NA","title":"Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2016-03","conditions":"Quality of Life","enrollment":6},{"nctId":"NCT03337256","phase":"NA","title":"Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy","status":"SUSPENDED","sponsor":"Chinese University of Hong Kong","startDate":"2015-09-01","conditions":"Upper Gastrointestinal Bleeding","enrollment":762},{"nctId":"NCT02460055","phase":"NA","title":"Trial- Dysphagia From ETT or GI Endoscopy","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2016-03","conditions":"Dysphagia, Respiratory Complications","enrollment":""},{"nctId":"NCT03758391","phase":"NA","title":"Comparison of Learning in Traditional Versus \"Flipped\" Classrooms","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2018-09-01","conditions":"Medical Education","enrollment":538},{"nctId":"NCT01945216","phase":"","title":"Alogliptin Tablets Special Drug Use Surveillance \"Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI\"","status":"COMPLETED","sponsor":"Takeda","startDate":"2010-07-08","conditions":"Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution","enrollment":3317},{"nctId":"NCT03886532","phase":"","title":"GI Medical Cannabis Study on IBD","status":"WITHDRAWN","sponsor":"Children's Hospital of Philadelphia","startDate":"2019-11-01","conditions":"Inflammatory Bowel Diseases, Neuropathic Pain","enrollment":""},{"nctId":"NCT02239120","phase":"PHASE3","title":"Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-11-27","conditions":"Stroke, Secondary Prevention","enrollment":5390},{"nctId":"NCT01374100","phase":"NA","title":"Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy","status":"TERMINATED","sponsor":"McGill University","startDate":"2009-02","conditions":"Carcinoma, Non-Small-Cell Lung, Cancer of the Gastrointestinal Tract","enrollment":52}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CHILLS"},{"count":1,"reaction":"NIGHT SWEATS"},{"count":1,"reaction":"VOMITING PROJECTILE"}],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"GI medication","genericName":"GI medication","companyName":"East Carolina University","companyId":"east-carolina-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a gastrointestinal medication developed by East Carolina University, but specific mechanism details are not publicly available. Used for Gastrointestinal disorder (specific indication unknown).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}